As part of their ongoing research on the physiologic factors that contribute to the development of obesity, Joslin Diabetes Center scientists have identified a cell cycle transcriptional co-regulator -- TRIP-Br2 -- that plays a major role in energy metabolism and fat storage. This finding has the potential to lead to new treatments for obesity. The study is being published January 6 ahead of print by Nature Medicine.
